Cambridge biotech Enumeral files for bankruptcy, sells cancer drugs ...
02/06/18
![]()
Cambridge biotech Enumeral files for bankruptcy, sells cancer drugs
Boston Business Journal
Eight months after announcing that it was winding down, Cambridge biotech Enumeral Biomedical has sold its experimental cancer drugs to a California-based company for $1.6 million and filed for bankruptcy. Enumeral (OTCQB: ENUM), whose stock had been ...
[more]
Boston Business Journal
Eight months after announcing that it was winding down, Cambridge biotech Enumeral Biomedical has sold its experimental cancer drugs to a California-based company for $1.6 million and filed for bankruptcy. Enumeral (OTCQB: ENUM), whose stock had been ...